Tech Company Financing Transactions

Mediar Therapeutics Funding Round

Mediar Therapeutics closed a $105 million funding round on 3/15/2023. Investors included Novartis Venture Fund, Sofinnova Partners and Bristol Myers Squibb.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

700 Main St.
North Cambridge, MA 02139
USA

Phone

Undisclosed

Website

www.mediartx.com

Email Address

[email protected]

Overview

Mediar is a discovery stage biotechnology company developing treatments to halt, or even reverse, fibrosis. Our platform and pipeline are based on an emerging class of novel targets -- fibrotic mediators -- that play key roles in modulating myofibroblasts.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Meredith Fisher

        

Chief Scientific Officer

Paul Yaworsky

        

Browse more venture capital transactions:

Prev: 3/15/2023: Ghost Message venture capital transaction
Next: 3/15/2023: HelloSelf venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on all VC transactions involving tech companies. All VC database entries on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary